Pfizer Vaccine Gets FDA Panel Review as Clearance Decis...
Word Count: 862 A Food and Drug Administration advisory panel gathered Thursday to consider issues including the safety of the shot from Pfizer Inc. and BioNTech SE, which employs a technology called messenger RNA that’s never before been used in human vaccines. The government is prepared with a safety monitoring system that will go into place the first day of the immunization campaign, said Nancy Messonnier, director of the Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases. “Vaccine safety and effective monitoring are a top priority ...